This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Titled "Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy AtrialFibrillation Ablation," the study was presented as a late-breaker at the 29th Annual International AF Symposium. 2,3 Approximately 1 in 4 adults over the age of 40 are at risk for developing AFib.4
Bernard's Heart & Vascular Center , Jonesboro, Arkansas) mark a significant milestone in the pursuit of innovative solutions for non-valvular atrialfibrillation (NVAF) treatment. Stroke is a major concern for millions of people living with atrialfibrillation, and as physicians, we strive to deliver better outcomes for these patients."
The first procedures were performed by Dr. David Newton , Clinical Cardiac Electrophysiologist at Memorial Health University Physicians Heart Care and Dr. Andrea Natale , Executive Medical Director at T exas Cardiac Arrhythmia Institute, St. Approximately 1 in 4 adults over the age of 40 are at risk for developing AFib.
PFA is designed to address AFib, the most common arrhythmia in the US, with a growing patient population. Antiarrhythmic drugs are typically a poor solution for AFib, as their side effects can be debilitating. The operational and safety benefits are “nice,” but AFib ablation has never really been a dangerous procedure.
By integrating AI into our products, we enable clinicians to make better use of data, streamline their workflows, and enhance patientcare. Command Center Software Platform: Command Center Software Platform provides a real-time and predictive control system for ongoing patientcare orchestration.
AFIB/AFL – atrialfibrillation or atrial flutter episodes. Overall, AI expedites ECG analysis by reducing manual effort, improving efficiency, and enabling timely detection of cardiac abnormalities, ultimately enhancing patientcare and outcomes. An abnormal electrocardiogram can mean many things.
cardiac electrophysiologist, performed one of the nations first procedures to control atrialfibrillation (Afib) using a new type of catheter that can deliver two different types of electrical energy or ablation to destroy the damaged part of the heart that is triggering the abnormal heartbeats. 12, 2025 On Feb.
The collaboration, according to a written statement issued by the company, aims to address challenges in capturing and analyzing cardiac signals to help physicians enhance patient outcomes for atrialfibrillation procedures. 1 Approximately 33 million patients worldwide are living with AFib.
Atrialfibrillation (AFib) cases have also surged, doubling from 28.3 This rise exacerbates the burden on overstretched cardiologists, who are facing a multitude of challenges like clinician shortages, complex workflows, administrative burden, poor patient adherence, health disparities and cost pressure. million in 2019.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content